“clinical-trials” Archives

in
Entry Author Date Location
FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning 11/16/17 San Francisco
X4 Pharma Pulls In $27M for Immune Drug in Cancer, Rare Diseases 11/16/17 Boston
Acorda Takes Another Hit, Reports Patient Deaths in Parkinson’s Study 11/15/17 New York
Inozyme Gets $49M From Sanofi, Novo to Tackle Rare Infant Disease 11/15/17 Boston
Locus Bio Raises $19M for CRISPR-Cas3 Antimicrobial “Smart Bombs” 11/14/17 Raleigh Durham
ImmusanT Gets $40M From Arch, Vatera to Continue Celiac Vaccine Quest 11/14/17 Boston
In a Precision Step, Bayer Writes Loxo $400M Check for Two Cancer Drugs 11/14/17 New York
With $25M, Torque Aims for a More Targeted Cell Therapy for Cancer 11/14/17 Boston
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
OncoResponse Buys Paganini Biopharma to Add Cancer Drug to Pipeline 11/08/17 Texas
With $40M for Exonics, Duchenne’s Gene Therapy, CRISPR Race Heats Up 11/08/17 Boston
$1B For Nothing? Valeant Sells Sex Drug to Sprout Backers for a Pittance 11/06/17 Raleigh Durham
Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More 11/03/17 National
Spero, Allena Nab $152M As Bio IPOs, With Insider Help, Continue Roll 11/02/17 Boston
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s 10/31/17 Boston
Corinnova Nets $6.1M from Wellcome for Heart Failure Medical Device 10/30/17 Texas
No Charm: PTC’s Duchenne Drug Rejected by FDA for Third Time 10/25/17 New York
Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug 10/23/17 Boston
Clinical Trial Lab Intrinsic Imaging Joins Rise of AI in Radiology 10/20/17 Texas
Bio Roundup: Kite’s CAR-T Approved, Obamacare Fix & Lilly mRNA Deal 10/20/17 National
For Key Study, UniQure Allowed to Swap Hemophilia Gene Therapies 10/19/17 Boston
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact 10/18/17 Indiana
Vir Biotech Vies for Global Approach to Tackling Infectious Disease 10/18/17 San Francisco
Gemini Reels In $42M to Target Root Causes of Age-Related Blindness 10/17/17 Boston
Phrixus to Launch Clinical Trials for Duchenne Drug in Early 2018 10/16/17 Detroit Ann Arbor
Spark’s Gene Therapy to Restore Vision Wins Unanimous FDA Panel Vote 10/12/17 New York
Merck Abandons Plans to Seek FDA Approval of Cholesterol Drug 10/11/17 New York
KalVista, Merck Partnership on Blindness Drug Sends Shares Skyward 10/10/17 Boston
Eli Lilly Drug Fails in Lung Cancer, Stalling Oncology Strategy 10/10/17 Indiana
Rhythm Pharma IPO Pops to the Tune of a $120M Upsized Offering 10/05/17 Boston
Page 1 of 28 next page »